Triheptanoin supplementation to ketogenic diet curbs cognitive impairment in APP/PS1 mice used as a model of familial Alzheimer's disease

Current Alzheimer Research

Volumn 10, Issue 3, 2013, Pages 290-297

  Aso, Ester ^a   Semakova, Jana ^b   Joda, Laura ^a   Semak, Vladislav ^b   Halbaut, Lyda ^b   Calpena, Ana ^b   Escolano, Carmen ^b   Perales, Jose C ^b   Ferrer, Isidro ^a,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Alzheimer's disease; Anaplerotic diet; APP PS1 transgenic mice; Ketone bodies; Mitochondria; Triheptanoin

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA INTERFERON; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; TRIHEPTANOIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN NERVE CELL; CELL PROLIFERATION; COGNITIVE DEFECT; CONTROLLED STUDY; ENERGY RESOURCE; FEMALE; KETOGENIC DIET; MACROGLIA; MEMORY DISORDER; MITOCHONDRION; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KETOGENIC DIET; MAZE LEARNING; MICE; MICE, TRANSGENIC; REAL-TIME POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 84876823225     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/15672050112099990128     Document Type: Article

References (38)

1. Aubert A, Costalat R, Magistretti PJ, Pellerin L. Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation. Proc Natl Acad Sci USA 102: 16448-53 (2005).
2. Pellerin L. Brain energetics (thought needs food). Curr Opin Clin Nutr Metab Care 11: 701-5 (2008).
3. Morris AA. Cerebral ketone body metabolism. J Inherit Metab Dis 28: 109-21 (2005).
4. Gasior M, Rogawski MA, Hartman AL. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol 17: 431-9 (2006).
5. Brunengraber H, Roe CR. Anaplerotic molecules: current and future. J Inherit Metab Dis 29: 327-31 (2006).
6. Deng S, Zhang GF, Kasumov T, Roe CR, Brunengraber H. Interrelations between C4 ketogenesis, C5 ketogenesis, and anaplerosis in the perfused rat liver. J Biol Chem 284: 27799-807 (2009).
7. Selkoe DJ. Alzheimer's disease. Cold Spring Harb Perspect Biol 3: 7 (2011).
8. Ferrer I. Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia. Prog Neurobiol 97: 38-51 (2012).
9. McGeer PL, McGeer EG. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22: 799-809 (2001).
10. de Vrij FM, Fischer DF, van Leeuwen FW, Hol EM. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. Prog Neurobiol 74: 249-70 (2004).
11. Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith MA, et al. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimers Dis 9: 147-53 (2006).
12. Ferrer I. Altered mitochondria, energy metabolism, voltagedependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J Bioenerg Biomembr 41: 425-31 (2009).
13. Sultana R, Butterfield DA. Role of oxidative stress in the progression of Alzheimer's disease. J Alzheimers Dis 19: 341-53 (2010).
14. Alzheimer's Association. Alzheimer's Disease Facts and Figures. Alzheimer's & Dementia 6: 9-14 (2010).
15. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19: 939-945 (1997).
16. Aso E, Lomoio S, López-González I, Joda L, Carmona M, Fernández-Yagüe N, et al. Amyloid generation and dysfunctional immunoproteasome activation with disease progression in an animal model of familial Alzheimer's disease. Brain Pathol 22(5): 636-53 (2012).
17. Van der Auwera I, Wera S, Van Leuven F, Henderson ST. A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (Lond) 2: 28 (2005).
18. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebocontrolled, multicenter trial. Nutr Metab (Lond) 6: 31 (2009).
19. Yao J, Chen S, Mao Z, Cadenas E, Brinton RD. 2-Deoxy-Dglucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PLoS One 6: e21788 (2011).
20. Semak V, Semakova J, Halbaut L, et al. Formulation of solid triheptanoin-rich ketogenic diet for rodents. Triheptanoin synthesis and pharmaceutical formulation. Eur J Lipid Sci Technol 114: 889-895 (2012).
21. Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ. Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis 20: 843-54 (2010).
22. Chen K, Ayutyanont N, Langbaum JB, Fleisher AS, Reschke C, Lee W, et al. Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage 56: 52-60 (2011).
23. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106: 14670-5 (2009).
24. Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol 5: 297-348 (2010).
25. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. Proc Natl Acad Sci USA 97: 5440-4 (2000).
26. Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 25: 311-4 (2004).
27. Cullingford TE. The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids 70: 253-64 (2004).
28. Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 56: 1376-86 (1991).
29. Guzmán M, Blázquez C. Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab 12: 169-73 (2001).
30. Escartin C, Pierre K, Colin A, Brouillet E, Delzescaux T, Guillermier M, et al. Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults. J Neurosci 27: 7094-104 (2007).
31. Gasparini L, Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci 8: 404-6 (2003).
32. Bonda DJ, Lee HG, Camins A, Pallàs M, Casadesus G, Smith MA, et al. The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurology 10: 275-9 (2011).
33. Chiarugi A, Moskowitz MA. Poly(ADP-ribose) polymerase-1 activity promotes NF-aaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 85: 306-317 (2003).
34. Murakami K, Murata N, Noda Y, Tahara S, Kaneko T, Kinoshita N, et al. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid rrrprotein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 286: 44557-68 (2011).
35. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70: 309-19 (2004).
36. Guzmán M, Blázquez C. Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot Essent Fatty Acids 70: 287-92 (2004).
37. Noh HS, Hah YS, Nilufar R, Han J, Bong JH, Kang SS, et al. Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J Neurosci Res 83: 702-9 (2006).
38. Noh HS, Kim YS, Lee HP, Chung KM, Kim DW, Kang SS, et al. The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res 53: 119-28 (2003).